Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 19577

1.

A case of Caplan syndrome in a recently diagnosed patient with silicosis: A case report.

Alaya Z, Braham M, Aissa S, Kalboussi H, Bouajina E.

Radiol Case Rep. 2018 Apr 11;13(3):663-666. doi: 10.1016/j.radcr.2018.03.004. eCollection 2018 Jun.

PMID:
30023036
2.

Paraneoplastic Seronegative Pauci-Immune Glomerulonephritis Associated with Lung Adenocarcinoma Responds to Rituximab: A Case Report.

Kancharla P, Surapaneni BK, Goldfinger M, Hennrick K, Ozeri DJ.

Case Rep Oncol. 2018 Jun 13;11(2):372-377. doi: 10.1159/000490101. eCollection 2018 May-Aug.

PMID:
30022938
3.

Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis.

Tonin FS, Steimbach LM, Leonart LP, Ferreira VL, Borba HH, Piazza T, Araújo AG, Fernandez-Llimos F, Pontarolo R, Wiens A.

Eur J Clin Pharmacol. 2018 Jul 18. doi: 10.1007/s00228-018-2524-3. [Epub ahead of print]

PMID:
30022333
4.

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.

Craig JW, Mina MJ, Crombie JL, LaCasce AS, Weinstock DM, Pinkus GS, Pozdnyakova O.

PLoS One. 2018 Jul 18;13(7):e0199708. doi: 10.1371/journal.pone.0199708. eCollection 2018.

5.

Cost of biologic treatment persistence or switching in rheumatoid arthritis.

Gu T, Mutebi A, Stolshek BS, Tan H.

Am J Manag Care. 2018 Jul;24(8 Spec No.):SP338-SP345.

6.

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.

Ma XB, Zhong YP, Zheng Y, Jiang J, Wang YP.

Cancer Med. 2018 Jul 17. doi: 10.1002/cam4.1674. [Epub ahead of print]

7.

Immunoglobulin-induced aseptic meningitis: a case report.

Graça L, Alves J, Nuak J, Sarmento A.

BMC Neurol. 2018 Jul 17;18(1):97. doi: 10.1186/s12883-018-1102-8.

8.

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma.

Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong X, Pei L, Rooney B, van de Velde H, Huang H.

Onco Targets Ther. 2018 Jul 6;11:3869-3882. doi: 10.2147/OTT.S150339. eCollection 2018.

9.

Sjögren's and plasma cell variant Castleman disease: a case report.

Dei-Adomakoh YA, Quarcoopome L, Abrahams AD, Segbefia CI, Dey DI.

Ghana Med J. 2018 Mar;52(1):61-65. doi: 10.4314/gmj.v52i1.9.

10.

A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic anemia due to ibrutinib treatment.

Suzuki T, Miyakoshi S, Nanba A, Uchiyama T, Kawamoto K, Aoki S.

J Clin Exp Hematop. 2018 Jul 14. doi: 10.3960/jslrt.18012. [Epub ahead of print]

11.

Gastrointestinal and Extra-intestinal Manifestations of Immunoglobulin G4-Related Disease.

Miyabe K, Zen Y, Cornell LD, Rajagopalan G, Chowdhary VR, Roberts LR, Chari ST.

Gastroenterology. 2018 Jul 13. pii: S0016-5085(18)34769-3. doi: 10.1053/j.gastro.2018.06.082. [Epub ahead of print] Review.

PMID:
30012334
12.

Long-term disease control in granulomatosis with polyangiitis: is low-dose rituximab the cure?

Trivioli G, Vaglio A.

Rheumatology (Oxford). 2018 Jul 12. doi: 10.1093/rheumatology/key204. [Epub ahead of print] No abstract available.

PMID:
30010880
13.

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial.

Park W, Božić-Majstorović L, Milakovic D, Berrocal Kasay A, El-Khouri EC, Irazoque-Palazuelos F, Molina FFC, Shesternya P, Miranda P, Medina-Rodriguez FG, Wiland P, Jeka S, Chavez-Corrales J, Garmish O, Linde T, Rekalov D, Hrycaj P, Krause A, Fomina N, Piura O, Abello-Banfi M, Suh CH, Shim SC, Lee SJ, Lee SY, Kim SH, Yoo DH.

MAbs. 2018 Jul 16:1-10. doi: 10.1080/19420862.2018.1487912. [Epub ahead of print]

PMID:
30010481
14.

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis.

Behin A, Le Panse R.

J Neuromuscul Dis. 2018 Jul 11. doi: 10.3233/JND-170294. [Epub ahead of print]

PMID:
30010142
15.

Reduced Intensity Conditioning and Dual T-Lymphocyte Suppression with Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide as Graft Versus Host Disease Prophylaxis In Haploidentical Stem Cell Transplants For Hematological Malignancies.

Law AD, Salas MQ, Lam W, Michelis FV, Thyagu S, Kim DDH, Lipton JH, Kumar R, Messner H, Viswabandya A.

Biol Blood Marrow Transplant. 2018 Jul 12. pii: S1083-8791(18)30395-1. doi: 10.1016/j.bbmt.2018.07.008. [Epub ahead of print]

PMID:
30009980
16.

Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real-world analysis from Taiwan Cancer Registry Database.

Huang HH, Wen YC, Chen HM, Hsiao FY, Ko BS.

Cancer Med. 2018 Jul 15. doi: 10.1002/cam4.1622. [Epub ahead of print]

17.

Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.

Noda Y, Saka Y, Kato A, Mimura T, Naruse T.

Clin Nephrol Case Stud. 2018 Jun 22;6:16-20. doi: 10.5414/CNCS109400. eCollection 2018.

18.

Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.

Shen H, Wei Z, Zhou D, Zhang Y, Han X, Wang W, Zhang L, Yang C, Feng J.

Oncol Lett. 2018 Aug;16(2):1602-1614. doi: 10.3892/ol.2018.8803. Epub 2018 May 24.

19.

Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma.

Oñate-Ocaña LF, Cortés V, Castillo-Llanos R, Terrazas A, Garcia-Perez O, Pitalúa-Cortes Q, Ponce M, Dueñas-Gonzalez A, Candelaria M.

Oncol Lett. 2018 Aug;16(2):1411-1418. doi: 10.3892/ol.2018.8817. Epub 2018 May 25.

20.

Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.

Pengo V, Denas G.

Thromb Res. 2018 Jul 7;169:35-40. doi: 10.1016/j.thromres.2018.07.011. [Epub ahead of print] Review.

PMID:
30007134

Supplemental Content

Loading ...
Support Center